Sequenom, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

SQNM 2.99 -0.05 (-1.48%)
price chart
Ariosa Diagnostics, Inc. v. Sequenom, Inc. – Another Diagnostic Patent Meets ...
On Friday, June 12, 2015, the Federal Circuit issued its decision in Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed.
Ariosa Diagnostics, Inc. v. Sequenom, Inc.: Federal Circuit finds not patent ...  Lexology (registration)
Sequenom Comments On US Court Of Appeals For The Federal Circuit Ruling ...  MarketWatch
Stock Update: Sequenom, Inc. (NASDAQ:SQNM)
Investors will be intently watching the EPS number that Sequenom, Inc. (NASDAQ:SQNM) reports when they announce their upcoming earnings.
Biotech Stocks To Look Out For - Sequenom, Inc. (NASDAQ:SQNM), Vertex ...
Dr. Mackey is currently the Chief Executive Officer of CYPrus Therapeutics, Inc., a privately-held small molecule pharmaceutical development company.
Stock Update (NASDAQ:SQNM): Sequenom, Inc. Welcomes Catherine J ...
Sequenom, Inc. (NASDAQ:SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced that its shareholders elected Catherine J. Mackey, Ph.
Sequenom Inc.: Sequenom Welcomes Catherine J. Mackey, Ph.D., To Board Of ...  The Wall Street Transcript
Sequenom, Inc. (NASDAQ:SQNM) revenue is starting to rise.
(Yahoo Finance contributor)Sequenom, Inc. (NASDAQ:SQNM) is a poster child for the dotcom bust. The stock debuted after the February 2000 IPO at 53.25 and rose to over $143 per share the next month, before a full on implosion to under $1 before the end ...
Why Sequenom Is Falling So Abruptly
Shares of Sequenom, Inc. (NASDAQ: SQNM) were down almost 10 percent on Thursday, after the company reported first quarter financial results below the Street's consensus estimates.
SEQUENOM's (SQNM) CEO William Welch on Q1 2015 Results - Earnings Call ...  Seeking Alpha
Sequenom Lowered to Hold at Zacks (SQNM)  Dakota Financial News
Sequenom, Inc. (NASDAQ:SQNM) Analyst Rating Update
Wall Street analysts polled by Zacks Research have given Sequenom, Inc. (NASDAQ:SQNM) a rating of 1.86 on a consensus basis.
Analysts Views: Sequenom, Inc. (NASDAQ:SQNM)
Wall Street Equity Research analysts evaluating future earnings growth for Sequenom, Inc. (NASDAQ:SQNM), are predicting that the company will report $-0.04 for the quarter ending on 2015-06-30.
Stock Update (NASDAQ:SQNM): Sequenom, Inc. Announces Private Exchange ...
Sequenom, Inc. (NASDAQ:SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced that it has entered into separate, privately negotiated exchange agreements with ...
Sequenom Announces Private Exchange Transactions Regarding Outstanding ...  PR Newswire (press release)
Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015)
Ariosa (and co-declaratory judgment plaintiffs Natera Inc. and Diagnostic Center, Inc.) filed a declaratory judgment action against Sequenom on these claims, and the District Court denied Sequenom's motion for preliminary injunction (in July 2012 ...
Federal Circuit Invalidates Diagnostic Method Claims for Prenatal Test Under ...  The National Law Review